Aqumeldi® is indicated for the treatment of heart failure in children from birth to less than 18 years1,2
Key Administration Information:
- Removes the need to adapt adult formulations.3-5
- Each mini orodispersible tablet is 2mm in size and contains 0.25mg or 1mg of enalapril maleate1,2
- Can be administered once or twice daily1,2
- Rapidly disperses in the mouth without the need for water3
- Multiple orodispersible tablets can be administered at the same time6,7
- Can be administered through feeding tubes when dispersed1,2
- 100 day expiry, once opened1,2
Watch videos of children being administered and self-administering Aqumeldi® replicas
Key Dosing Information2
Please refer to the full SmPC before prescribing.
Starting/test dose: 0.01 to 0.04 mg/kg (max 2mg) as a single initial dose
Target/maintenance dose: 0.15 to 0.3 mg/kg (max 20 mg) per day in one or two divided doses. The dose should be individualised according to blood pressure, serum creatinine and potassium response.
Guidance on doses under 0.25mg: Doses less than 0.25mg can be achieved by placing one 0.25mg tablet in a 10ml oral syringe, adding tap water (sterile water if <6months) to the 10ml graduation, rolling the syringe for 3 minutes to fully disperse the tablet and administering the required volume immediately to the patient (1ml will contain 0.025mg enalapril).
Aqumeldi® is now listed in the BNFC8
Example dosing schedules for patients prescribed Aqumeldi®
* Doses have been rounded to the nearest whole ODT. Dose rounding is at the prescribers discretion. Please visit the SmPC for information relating to dosing below 0.25mg.
